2025 |
Collegium Pharmaceutical Inc
|
Independent Director |
- |
- |
2024 |
Soleno Therapeutics Inc
|
Independent Director |
23.9 K |
-76.2 % |
2024 |
Gain Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
Collegium Pharmaceutical Inc
|
Independent Director |
- |
- |
2023 |
Collegium Pharmaceutical Inc
|
Independent Director |
275.6 K |
-1.3 % |
2023 |
Soleno Therapeutics Inc
|
- |
100.4 K |
87.8 % |
2022 |
Collegium Pharmaceutical Inc
|
Independent Director |
279.3 K |
-6.1 % |
2022 |
Gain Therapeutics Inc
|
Independent Director |
64.8 K |
-38.6 % |
2022 |
Soleno Therapeutics Inc
|
Independent Director |
53.5 K |
-63.1 % |
2021 |
Collegium Pharmaceutical Inc
|
Independent Director |
297.6 K |
19.6 % |
2021 |
Soleno Therapeutics Inc
|
Independent Director |
144.9 K |
135.7 % |
2021 |
Gain Therapeutics Inc
|
Independent Director |
105.6 K |
- |
2020 |
Collegium Pharmaceutical Inc
|
Independent Director |
248.7 K |
26.9 % |
2020 |
Soleno Therapeutics Inc
|
Independent Director |
61.5 K |
-17.8 % |
2020 |
Gain Therapeutics Inc
|
Independent Director |
- |
- |
2019 |
Collegium Pharmaceutical Inc
|
Independent Director |
196.0 K |
16.5 % |
2019 |
Soleno Therapeutics Inc
|
Independent Director |
74.8 K |
- |
2018 |
Collegium Pharmaceutical Inc
|
Independent Director |
168.2 K |
7.2 % |
2018 |
Soleno Therapeutics Inc
|
Director |
- |
- |
2018 |
Kamada Ltd
|
Independent Director |
- |
- |
2017 |
Collegium Pharmaceutical Inc
|
Director |
156.8 K |
- |
2017 |
Kamada Ltd
|
Independent Director |
- |
- |
2016 |
Kamada Ltd
|
Independent Director |
- |
- |